SX-682 + Enzalutamide in Abiraterone-Resistant mCRPC
Clinical Trial Grant
Administered By
Medicine, Medical Oncology
Awarded By
Syntrix Biosystems, Inc.
Start Date
August 27, 2024
End Date
June 30, 2027
Administered By
Medicine, Medical Oncology
Awarded By
Syntrix Biosystems, Inc.
Start Date
August 27, 2024
End Date
June 30, 2027